Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Teleflex (TFX) Q4 Earnings: What To Expect
Teleflex (TFX) Q4 Earnings: What To Expect
Teleflex (TFX) Q4 Earnings: What To Expect
Kayode Omotosho
Thu, February 26, 2026 at 1:16 AM GMT+9 2 min read
In this article:
TFX
-0.44%
Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow before market hours. Here’s what to expect.
Teleflex met analysts’ revenue expectations last quarter, reporting revenues of $892.9 million, up 16.8% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ EPS estimates.
Is Teleflex a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Teleflex’s revenue to grow 15.9% year on year, improving from the 2.8% increase it recorded in the same quarter last year.
Teleflex Total Revenue
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Teleflex has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Teleflex’s peers in the healthcare equipment and supplies segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 18.8%, beating analysts’ expectations by 1%, and Envista reported revenues up 15%, topping estimates by 10.6%. Intuitive Surgical’s stock price was unchanged after the resultswhile Envista was up 17.8%.
Read our full analysis of Intuitive Surgical’s results here and Envista’s results here.
Investors in the healthcare equipment and supplies segment have had fairly steady hands going into earnings, with share prices down 1.9% on average over the last month. Teleflex is up 7.3% during the same time and is heading into earnings with an average analyst price target of $129.25 (compared to the current share price of $112.12).
Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Terms and Privacy Policy
Privacy Dashboard
More Info